Detalles de la búsqueda
1.
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study.
Breast Cancer Res Treat
; 134(1): 283-9, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22476856
2.
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
Clin Cancer Res
; 14(6): 1797-803, 2008 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18347182
3.
A pilot study of a day one and eight every three weeks administration of docetaxel in metastatic cancer patients.
Tumori
; 93(2): 145-9, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17557560
4.
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.
Clin Cancer Res
; 15(15): 4954-62, 2009 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19622584
5.
5-fluorouracil administered as a 48-hour semiintermittent infusion in combination with leucovorin, cisplatin and epirubicin: phase II study in advanced gastric cancer patients.
Am J Clin Oncol
; 27(1): 101-5, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14758142
Resultados
1 -
5
de 5
1
Próxima >
>>